Three new radiopharmacy devices have been added to GE Medical Systems' line of Tracerlab chemistry synthesis products. The products, unveiled Oct. 24 at the Academy of Molecular Imaging conference, are used to generate positron-emitting radiopharmaceuticals. The Tracerlab FXFDopa, Tracerlab FXF-E, and Tracerlab FXF-N synthesize targeted F-18 radiopharmaceuticals for molecular imaging research. The devices are compatible with all commercially available cyclotrons, according to the company.
